ReviewDie Anaesthesiologie2026
[Autoimmune encephalitis in intensive care medicine : Differentiation from infectious encephalitis].
Review in Die Anaesthesiologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune encephalitis (AIE) is a relatively new group within the spectrum of encephalitic diseases. Awareness and the pathophysiological understanding of these conditions are increasing. They are also gaining importance in the field of intensive care medicine as severe cases are frequently accompanied by unconsciousness, epileptic seizures up to treatment-refractory status epilepticus, autonomic dysregulation and the need for mechanical ventilation. A major challenge is the early differentiation between autoimmune and infectious encephalitides as symptoms, cerebrospinal fluid findings and changes in imaging examinations can often appear similar. While infectious encephalitis requires rapid anti-infective therapy, autoimmune forms necessitate early initiation of immunotherapy. Delays in commencing treatment worsen the prognosis. This article addresses the diagnostic criteria, antibody diagnostics, complications in intensive care settings and current immunotherapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.